These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38860604)

  • 21. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.
    Barrett MT; Lenkiewicz E; Malasi S; Basu A; Yearley JH; Annamalai L; McCullough AE; Kosiorek HE; Narang P; Wilson Sayres MA; Chen M; Anderson KS; Pockaj BA
    Breast Cancer Res; 2018 Jul; 20(1):71. PubMed ID: 29996881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
    Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
    Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer.
    Zhang W; Wang X; Dong J; Wang K; Jiang W; Fan C; Liu H; Fan L; Zhao L; Li G
    J Cell Mol Med; 2024 Jun; 28(12):e18373. PubMed ID: 38894657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
    Ju X; Zhang H; Zhou Z; Chen M; Wang Q
    Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer.
    Mu L; Yu W; Su H; Lin Y; Sui W; Yu X; Qin C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1036-1042. PubMed ID: 30983436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.
    He W; Li Y; Chen X; Lu L; Tang B; Wang Z; Pan Y; Cai S; He Y; Ke Z
    J Gastroenterol Hepatol; 2014; 29(7):1427-34. PubMed ID: 24612089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer.
    Hashimoto T; Kurokawa Y; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Ikeda JI; Mori M; Doki Y
    Gastric Cancer; 2019 Jul; 22(4):785-792. PubMed ID: 30617648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC).
    Liu YJ; Ye QW; Li JP; Bai L; Zhang W; Wang SS; Zou X
    Sci Rep; 2024 Sep; 14(1):22596. PubMed ID: 39349535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
    Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
    BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
    Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer.
    Chen X; Mao D; Li D; Li W; Wei H; Deng C; Chen H; Zhang C
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5871-5884. PubMed ID: 36592213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.
    Ju Y; Wang Z; Wang Q; Jin S; Sun P; Wei Y; Zhu G; Wang K
    J Cell Mol Med; 2024 Aug; 28(15):e18579. PubMed ID: 39086142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNHG15-mediated feedback loop interplays with HNRNPA1/SLC7A11/GPX4 pathway to promote gastric cancer progression.
    Duan Y; Yan Y; Fu H; Dong Y; Li K; Ye Z; Dou Y; Huang B; Kang W; Wei GH; Cai Q; Xu D; Zhou D
    Cancer Sci; 2024 Jul; 115(7):2269-2285. PubMed ID: 38720175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer.
    Li L; Fei Y; Dong T; Song Y; Chen X; Zhang H; Zhou H; Liang M; Tang J
    Int Immunopharmacol; 2024 May; 133():112093. PubMed ID: 38669947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of ARID1A negative expression in gastric cancer.
    Ashizawa M; Saito M; Min AKT; Ujiie D; Saito K; Sato T; Kikuchi T; Okayama H; Fujita S; Endo H; Sakamoto W; Momma T; Ohki S; Goto A; Kono K
    Sci Rep; 2019 May; 9(1):6769. PubMed ID: 31043675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Ubukata Y; Ogata K; Sohda M; Yokobori T; Shimoda Y; Handa T; Nakazawa N; Kimura A; Kogure N; Sano A; Sakai M; Ogawa H; Kuwano H; Shirabe K; Oyama T; Saeki H
    Oncology; 2021; 99(1):15-22. PubMed ID: 33113541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.